Latest Product News

Product News
Voltron Therapeutics, Inc. Announces Sponsored Research Agreement With the Massachusetts General Hospital, Harvard Medical School, To Initiate a Pre-Clinical Immuno-Oncology Trial
Voltron Therapeutics, Inc. has signed a new Sponsored Research Agreement with the Vaccine and Immunotherapy Center at Massachusetts General Hospital, Harvard Medical School to initiate a pre-clinical immuno-oncology trial targeting prostate stem cell antigen in prostate, renal cell and urothelial cancers, adding important potential indications to its growing pipeline.

Product News
Personalis and Moderna Sign New Agreement To Leverage NeXT Platform™ in Personalized mRNA Cancer Vaccine Clinical Trials
The platform will be used to sequence genomic information from a patient’s tumor sample to identify the unique genetic mutations that are most likely to generate a tailored antitumor response.

Product News
FUJIFILM Irvine Scientific Launches HEK293 Feed, Specifically Designed for Viral Vector Production
FUJIFILM Irvine Scientific, Inc. has announced the launch of its BalanCD HEK293 Viral Feed.

Product News
Particle Works Launches ALiS – An Automated and High-Throughput Platform for LNP Formulation Screening
Particle Works continues to pave the way for particle perfection with the highly anticipated launch of its second revolutionary platform, the Automated Library Synthesis (ALiS) System.

Product News
Biochemical Analytics Prize Awarded to Scientists for the Development of a High-Resolution Lipid Profile and the Discovery of the Causes of Vaccine-Induced Cerebral Vein Thrombosis
This year, the Biochemical Analytics Prize, endowed with 50,000 euros, will be
awarded to biochemistry professor, Dr Kai Simons and analytical chemist, Dr
Andrej Shevchenko, as well as to Professor Andreas Greinacher, a transfusion
medicine physician.
awarded to biochemistry professor, Dr Kai Simons and analytical chemist, Dr
Andrej Shevchenko, as well as to Professor Andreas Greinacher, a transfusion
medicine physician.

Product News
Thermo Fisher Scientific Introduces Customized Dynabeads Solutions for Scalable mRNA Production
The Dynabeads™ Streptavidin for in vitro transcription and Dynabeads Carboxylic Acid for RNA purification solutions support scalable GMP-grade synthesis and purification of mRNA for vaccine development and manufacturing.

Product News
Peli BioThermal Launches Crēdo™ Go Cold Chain Shipping Solution
Peli BioThermal announces its newest reusable, flexible temperature-controlled shipping solution.

Product News
Voltron Therapeutics, Inc. Announces Definitive Proof of Concept Data for its Lead Oncology Candidate
Voltron Therapeutics, Inc. has announced that data from the previously announced Study ‘098 demonstrated clear Proof-of Concept for VTX-067 in the treatment of HPV-related cancers.

Product News
Vaccizone Selects Exothera for Process Development and GMP Manufacturing of its SARS-CoV-2 Vaccine
Vaccizone has selected Exothera S.A. to fast-track process development of its SARS-CoV-2 vaccine for European clinical trials.

Product News
Voltron Therapeutics, Inc., a Lucius Partners Company, Announces Initiation of Key Preclinical Study of VTX-067 in Immuno-Oncology
Lucius Partners, LLC has reported that its portfolio company, Voltron Therapeutics, Inc., had announced the initiation of a preclinical study of its novel vaccine candidate VTX-067 in an immune-oncology model.
Advertisement